EOLS
NASDAQ · Pharmaceuticals
Evolus Inc
$6.63
-0.11 (-1.63%)
Open$6.77
Previous Close$6.74
Day High$6.90
Day Low$6.53
52W High$10.20
52W Low$3.86
Volume—
Avg Volume802.2K
Market Cap436.62M
P/E Ratio—
EPS$-0.67
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
+673.6% upside
Current
$6.63
$6.63
Target
$51.29
$51.29
$37.24
$51.29 avg
$70.77
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 299.05M | 237.36M | 74.40M |
| Net Income | -51,965,856 | -37,121,414 | 20.76M |
| Profit Margin | -17.4% | -16.5% | 27.9% |
| EBITDA | -26,553,839 | -20,022,340 | 38.85M |
| Free Cash Flow | — | — | 15.01M |
| Rev Growth | +26.0% | +26.0% | +16.8% |
| Debt/Equity | 22.00 | 22.00 | 0.90 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |